Literature DB >> 9309124

A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 approximately 21;q11.2 approximately 21).

Y Hennig1, J Caselitz, S Bartnitzke, J Bullerdiek.   

Abstract

Cytogenetic analysis of a low-grade endometrial stromal sarcoma of the uterus in a 52-year-old woman revealed the karyotype 46,XX,t(7;17)(p14 approximately 21;q11.2 approximately 21),der(7)t(7;16)(p14-15;q22)t(7;9) (q22;q22), der(9)t(7;9)(q22;q22),del(16)(q22). The t(7;17) was identical to an aberration observed in two other cases of endometrial stromal sarcomas, thus confirming the idea that it constitutes a non-random aberration for this type of tumor.

Entities:  

Mesh:

Year:  1997        PMID: 9309124     DOI: 10.1016/s0165-4608(96)00393-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

Review 1.  JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.

Authors:  Andelko Hrzenjak; Farid Moinfar; Fattaneh A Tavassoli; Bettina Strohmeier; Marie-Luise Kremser; Kurt Zatloukal; Helmut Denk
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

2.  Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors.

Authors:  J I Koontz; A L Soreng; M Nucci; F C Kuo; P Pauwels; H van Den Berghe; P Dal Cin; J A Fletcher; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 3.  LG-ESSs and HG-ESSs: underlying molecular alterations and potential therapeutic strategies.

Authors:  Chunhui Li; Chunhong Wang
Journal:  J Zhejiang Univ Sci B       Date:  2021-08-15       Impact factor: 3.066

4.  Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival.

Authors:  Hui Li; Xianyong Ma; Jinglan Wang; Jason Koontz; Marisa Nucci; Jeffrey Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.